Transgenics can substantially reduce capital investment and lower production costs through economies of scale and more flexible scale-up.
Cory Nykiforuk, Ph.D.
Advertisement
Articles by Cory Nykiforuk, Ph.D.
Advertisement
Latest Updated Articles
Producing Proteins Using Transgenic Oilbody-Oleosin TechnologyPublished: June 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
